Iain B. Mcinnes
University Avenue
Glasgow, SCT, United Kingdom
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 460 publications
Immune-Mediated Inflammatory Diseases and the Critically Ill.
Journal: Critical care clinics
Published: September 02, 2026
Author Correction: Diagnostic, prognostic and therapeutic biomarkers in rheumatoid arthritis.
Journal: Nature reviews. Rheumatology
Published: August 24, 2026
Diagnostic, prognostic and therapeutic biomarkers in rheumatoid arthritis.
Journal: Nature reviews. Rheumatology
Published: May 15, 2026
Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison.
Journal: Rheumatology and therapy
Published: April 08, 2026
Investigating the molecular drivers of high-level clinical responses to bimekizumab in psoriatic disease: Introducing the BE UNIQUE phase 3b study.
Journal: The Journal of investigative dermatology
Published: February 27, 2026
Evolving landscape of JAK-STAT inhibition in the treatment of immune-mediated inflammatory diseases.
Evolving landscape of JAK-STAT inhibition in the treatment of immune-mediated inflammatory diseases.
Journal: The Journal of allergy and clinical immunology
Published: February 02, 2026
Bridging the gap: combining treat-to-target and difficult-to-treat strategies in the management of rheumatoid arthritis.
Journal: Nature reviews. Rheumatology
Published: January 23, 2026
The ontogeny of myeloid-stromal synovial tissue niches in rheumatoid arthritis.
Journal: Research square
Published: December 03, 2025
The ontogeny of myeloid-stromal synovial tissue niches in rheumatoid arthritis.
Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025
Cracking the code of therapeutic failure in inflammatory rheumatic diseases: collaborative pathways bridging academia, industry, and patient-centric innovation.
Journal: Annals of the rheumatic diseases
Published: November 11, 2025
Long-term outcomes of abatacept in individuals at risk of developing rheumatoid arthritis (ALTO): a randomised, double-blind, placebo-controlled trial.
Journal: The Lancet. Rheumatology
Published: November 11, 2025
Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies.
Journal: Rheumatology (Oxford, England)
Published: October 28, 2025
Last Updated: 09/26/2026